Terminal differentiation of human breast cancer through PPAR gamma. (Q47858529)

6 February 2018

title

Terminal differentiation of human breast cancer through PPAR gamma. (English)

1 reference

6 February 2018

1 reference

E Mueller

1

1 reference

6 February 2018

P Sarraf

2

1 reference

6 February 2018

P Tontonoz

3

1 reference

6 February 2018

R M Evans

4

1 reference

6 February 2018

K J Martin

5

1 reference

6 February 2018

M Zhang

6

1 reference

6 February 2018

C Fletcher

7

1 reference

6 February 2018

S Singer

8

1 reference

6 February 2018

B M Spiegelman

9

1 reference

6 February 2018

publication date

1 February 1998

1 reference

6 February 2018

published in

Molecular Cell

1 reference

6 February 2018

volume

1

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

465-470

1 reference

6 February 2018

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Sublines of mouse 3T3 cells that accumulate lipid

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

1 reference

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Clinical highlights from the National Cancer Data Base: 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Hyperexpression of mitogen-activated protein kinase in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Delayed mammary tumor progression in Muc-1 null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980047-7

7 January 2021

10.1016/S1097-2765(00)80047-7

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9660931

1 reference

6 February 2018